Female Health ROA 2006-2020 | VERU
Current and historical return on assets (ROA) values for Female Health (VERU) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Female Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2020-06-30 | $-0.01B | $0.07B | -17.39% |
| 2020-03-31 | $-0.01B | $0.06B | -18.26% |
| 2019-12-31 | $-0.01B | $0.06B | -24.30% |
| 2019-09-30 | $-0.01B | $0.05B | -22.75% |
| 2019-06-30 | $-0.02B | $0.05B | -33.17% |
| 2019-03-31 | $-0.02B | $0.05B | -43.14% |
| 2018-12-31 | $-0.02B | $0.05B | -41.71% |
| 2018-09-30 | $-0.02B | $0.05B | -45.71% |
| 2018-06-30 | $-0.02B | $0.05B | -38.71% |
| 2018-03-31 | $-0.01B | $0.06B | -25.34% |
| 2017-12-31 | $-0.01B | $0.05B | -21.82% |
| 2017-09-30 | $-0.01B | $0.06B | -15.65% |
| 2017-06-30 | $-0.01B | $0.06B | -11.21% |
| 2017-03-31 | $-0.00B | $0.06B | -8.08% |
| 2016-12-31 | $-0.00B | $0.06B | -4.42% |
| 2016-09-30 | $0.00B | $0.04B | 0.00% |
| 2016-06-30 | $0.00B | $0.04B | 7.64% |
| 2016-03-31 | $0.00B | $0.04B | 7.84% |
| 2015-12-31 | $0.01B | $0.04B | 13.42% |
| 2015-09-30 | $0.01B | $0.04B | 13.99% |
| 2015-06-30 | $0.00B | $0.04B | 8.70% |
| 2015-03-31 | $0.00B | $0.04B | 8.96% |
| 2014-12-31 | $0.00B | $0.03B | 3.05% |
| 2014-09-30 | $0.00B | $0.03B | 3.01% |
| 2014-06-30 | $0.01B | $0.03B | 26.47% |
| 2014-03-31 | $0.01B | $0.03B | 26.67% |
| 2013-12-31 | $0.01B | $0.04B | 35.56% |
| 2013-09-30 | $0.02B | $0.04B | 46.15% |
| 2013-06-30 | $0.02B | $0.03B | 51.20% |
| 2013-03-31 | $0.02B | $0.03B | 61.02% |
| 2012-12-31 | $0.02B | $0.03B | 62.96% |
| 2012-09-30 | $0.02B | $0.03B | 64.65% |
| 2012-06-30 | $0.01B | $0.03B | 59.09% |
| 2012-03-31 | $0.01B | $0.02B | 51.28% |
| 2011-12-31 | $0.01B | $0.02B | 45.07% |
| 2011-09-30 | $0.01B | $0.02B | 29.85% |
| 2011-06-30 | $0.01B | $0.02B | 36.36% |
| 2011-03-31 | $0.01B | $0.02B | 36.92% |
| 2010-12-31 | $0.01B | $0.02B | 49.23% |
| 2010-09-30 | $0.01B | $0.02B | 44.44% |
| 2010-06-30 | $0.00B | $0.01B | 18.75% |
| 2010-03-31 | $0.00B | $0.02B | 24.62% |
| 2009-12-31 | $0.00B | $0.02B | 25.81% |
| 2009-09-30 | $0.01B | $0.02B | 47.46% |
| 2009-06-30 | $0.01B | $0.02B | 51.85% |
| 2009-03-31 | $0.01B | $0.01B | 53.85% |
| 2008-12-31 | $0.01B | $0.01B | 46.15% |
| 2008-09-30 | $0.01B | $0.01B | 37.74% |
| 2008-06-30 | $0.00B | $0.01B | 32.00% |
| 2008-03-31 | $0.00B | $0.01B | 26.09% |
| 2007-12-31 | $0.00B | $0.01B | 19.05% |
| 2007-09-30 | $0.00B | $0.01B | 10.81% |
| 2007-06-30 | $0.00B | $0.01B | 0.00% |
| 2007-03-31 | $0.00B | $0.01B | 0.00% |
| 2006-12-31 | $0.00B | $0.01B | 0.00% |
| 2006-09-30 | $0.00B | $0.01B | 0.00% |
| 2006-06-30 | $0.00B | $0.01B | 0.00% |
| 2006-03-31 | $0.00B | $0.01B | 0.00% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.184B | $0.032B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.682B | 33.53 |
| Medtronic (MDT) | Ireland | $136.129B | 25.64 |
| Stryker (SYK) | United States | $74.576B | 28.92 |
| Boston Scientific (BSX) | United States | $53.107B | 30.68 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.620B | 0.00 |
| Baxter (BAX) | United States | $39.840B | 24.37 |
| Terumo (TRUMY) | Japan | $30.003B | 38.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $27.355B | 22.70 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $27.164B | 0.00 |
| ResMed (RMD) | United States | $24.364B | 35.32 |
| Sunny Optical Technology (SNPTF) | China | $17.659B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.383B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.666B | 66.33 |
| Insulet (PODD) | United States | $14.217B | 601.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.080B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.350B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $10.221B | 52.10 |
| Quidel (QDEL) | United States | $8.053B | 42.66 |
| William Demant Holdings (WILYY) | Denmark | $7.100B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.140B | 10.54 |
| Hill-Rom Holdings (HRC) | United States | $5.406B | 13.42 |
| Canopy Growth (CGC) | Canada | $5.305B | 0.00 |
| Haemonetics (HAE) | United States | $4.393B | 29.27 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.250B | 0.00 |
| Neogen (NEOG) | United States | $3.902B | 63.97 |
| ICU Medical (ICUI) | United States | $3.841B | 29.31 |
| Envista Holdings (NVST) | United States | $3.701B | 25.24 |
| Abcam (ABCZY) | $3.220B | 0.00 | |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.058B | 0.00 |
| TG Therapeutics (TGTX) | United States | $3.007B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.947B | 458.00 |
| NuVasive (NUVA) | United States | $2.507B | 34.94 |
| Agios Pharmaceuticals (AGIO) | United States | $2.341B | 0.00 |
| AtriCure (ATRC) | United States | $1.724B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.632B | 148.92 |
| NanoString Technologies (NSTG) | United States | $1.620B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.415B | 0.00 |
| MacroGenics (MGNX) | United States | $1.336B | 0.00 |
| Owens & Minor (OMI) | United States | $1.295B | 29.01 |
| Aphria (APHA) | Canada | $1.218B | 0.00 |
| InMode (INMD) | Israel | $1.125B | 28.37 |
| Cerus (CERS) | United States | $0.980B | 0.00 |
| Quanterix (QTRX) | United States | $0.898B | 0.00 |
| PetIQ (PETQ) | United States | $0.882B | 25.30 |
| BioLife Solutions (BLFS) | United States | $0.835B | 435.00 |
| Lantheus Holdings (LNTH) | United States | $0.804B | 11.14 |
| OraSure Technologies (OSUR) | United States | $0.762B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.713B | 16.32 |
| LeMaitre Vascular (LMAT) | United States | $0.685B | 41.80 |
| Meridian Bioscience (VIVO) | United States | $0.665B | 15.36 |
| Vapotherm (VAPO) | United States | $0.650B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.600B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.560B | 79.08 |
| Zynex (ZYXI) | United States | $0.553B | 48.27 |
| Omeros (OMER) | United States | $0.536B | 0.00 |
| Surmodics (SRDX) | United States | $0.517B | 56.72 |
| VAREX IMAGING (VREX) | United States | $0.460B | 19.93 |
| Cytosorbents (CTSO) | United States | $0.327B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.325B | 11.61 |
| HEXO (HEXO) | $0.312B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.285B | 24.44 |
| InfuSystems Holdings (INFU) | United States | $0.265B | 50.42 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.242B | 0.00 |
| Surface Oncology (SURF) | United States | $0.240B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
| Chimerix (CMRX) | United States | $0.164B | 0.00 |
| Bovie Medical (APYX) | United States | $0.154B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.152B | 0.00 |
| Fonar (FONR) | United States | $0.142B | 12.58 |
| Exagen (XGN) | United States | $0.137B | 0.00 |
| Liberty Health Sciences (LHSIF) | United States | $0.128B | 0.00 |
| Evolus (EOLS) | United States | $0.122B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.098B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.085B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.084B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.077B | 0.00 |
| United-Guardian (UG) | United States | $0.069B | 15.39 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.065B | 0.00 |
| Brainsway (BWAY) | Israel | $0.061B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.050B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.048B | 9.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.034B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.019B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.018B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.018B | 0.00 |
| Myomo (MYO) | United States | $0.016B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.016B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
